Profile data is unavailable for this security.
About the company
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
- Revenue in USD (TTM)3.00bn
- Net income in USD-10.10m
- Incorporated2021
- Employees7.10k
- LocationQuidelOrtho Corp9975 Summers Ridge RoadSAN DIEGO 92121United StatesUSA
- Phone+1 (858) 552-1100
- Fax+1 (858) 453-4338
- Websitehttps://www.quidelortho.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NeoGenomics, Inc. | 591.64m | -87.97m | 1.81bn | 2.10k | -- | 1.92 | -- | 3.06 | -0.7015 | -0.7015 | 4.71 | 7.39 | 0.3459 | 14.33 | 4.68 | 281,734.80 | -5.14 | -3.57 | -5.44 | -3.80 | 41.34 | 41.09 | -14.87 | -9.36 | 5.95 | -- | 0.3637 | -- | 16.07 | 16.41 | 39.02 | -- | 14.98 | -- |
| Astrana Health Inc | 1.39bn | 60.72m | 1.81bn | 1.80k | 28.96 | 2.86 | 23.94 | 1.31 | 1.29 | 1.29 | 29.56 | 13.11 | 1.46 | -- | 11.07 | 770,367.80 | 6.09 | 7.09 | 6.73 | 9.39 | 15.50 | 18.30 | 4.17 | 6.36 | -- | -- | 0.4055 | 10.54 | 21.19 | 21.68 | 34.42 | 41.16 | 89.42 | -- |
| Brightspring Health Services Inc | 8.83bn | -154.60m | 1.83bn | 35.00k | -- | 2.16 | 40.26 | 0.2075 | -0.9204 | -0.9204 | 57.53 | 4.96 | -- | -- | -- | 252,176.40 | -- | -- | -- | -- | 16.24 | 17.75 | -1.78 | -0.6289 | 0.8442 | 0.9783 | 0.8473 | -- | 14.32 | 28.33 | -186.80 | -- | 17.24 | -- |
| Agilon Health Inc | 4.32bn | -195.05m | 2.20bn | 1.12k | -- | 3.28 | -- | 0.5085 | -0.4885 | -0.6576 | 10.51 | 1.63 | 2.51 | -- | 5.99 | 3,864,246.00 | -11.36 | -- | -20.26 | -- | 7.13 | -- | -4.52 | -- | -- | -13,643.82 | 0.0551 | -- | 80.74 | -- | -112.01 | -- | -- | -- |
| Privia Health Group Inc | 1.66bn | 23.08m | 2.23bn | 1.10k | 101.51 | 3.96 | 80.94 | 1.35 | 0.1852 | 0.1852 | 13.30 | 4.75 | 1.85 | -- | 6.90 | 1,504,299.00 | 2.35 | -- | 3.91 | -- | 9.74 | 9.15 | 1.27 | -2.56 | -- | -- | 0.00 | -- | 22.19 | 20.31 | 368.83 | -- | -12.48 | -- |
| Lifestance Health Group Inc | 1.06bn | -186.26m | 2.33bn | 9.33k | -- | 1.62 | -- | 2.20 | -0.5059 | -0.5059 | 2.87 | 3.77 | 0.4929 | -- | 9.33 | 113,208.00 | -8.70 | -- | -9.54 | -- | -- | -- | -17.64 | -- | -- | -5.69 | 0.1654 | -- | 22.82 | -- | 13.59 | -- | -- | -- |
| Teladoc Health Inc | 2.60bn | -220.37m | 2.33bn | 5.60k | -- | 0.9844 | 19.93 | 0.8939 | -1.34 | -1.34 | 15.81 | 13.96 | 0.5957 | 17.70 | 12.16 | 464,717.00 | -5.04 | -33.54 | -5.57 | -34.63 | 70.80 | 68.59 | -8.47 | -171.39 | 3.47 | -- | 0.3981 | -- | 8.13 | 44.16 | 98.39 | -- | 79.43 | -- |
| Quidelortho Corp | 3.00bn | -10.10m | 2.70bn | 7.10k | -- | 0.5383 | 6.04 | 0.9013 | -0.1542 | -0.1542 | 44.81 | 75.05 | 0.3442 | 2.73 | 7.03 | 422,225.30 | -0.116 | 11.34 | -0.1297 | 12.91 | 49.85 | 62.71 | -0.3369 | 20.93 | 0.8788 | 1.71 | 0.3254 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
| Amedisys Inc | 2.24bn | -9.75m | 2.98bn | 19.00k | -- | 2.79 | 230.65 | 1.33 | -0.3078 | -0.3078 | 68.45 | 32.65 | 1.11 | -- | 7.33 | 117,704.30 | -0.5419 | 7.82 | -0.7058 | 10.39 | 44.31 | 43.63 | -0.489 | 5.89 | -- | 10.03 | 0.2623 | 0.00 | 0.593 | 6.11 | -108.22 | -- | 14.16 | -- |
| Progyny Inc | 1.09bn | 62.04m | 3.11bn | 563.00 | 52.56 | 5.64 | 48.42 | 2.86 | 0.6164 | 0.6164 | 10.81 | 5.74 | 1.68 | -- | 4.52 | 1,933,567.00 | 9.55 | 11.50 | 13.00 | 16.02 | 21.94 | 21.48 | 5.70 | 6.64 | -- | -- | 0.00 | 0.00 | 38.34 | 59.52 | 104.35 | -- | 44.47 | -- |
| Surgery Partners Inc | 2.74bn | -11.90m | 3.21bn | 10.50k | -- | 1.62 | 12.68 | 1.17 | -0.0974 | -0.0974 | 21.77 | 15.70 | 0.4047 | 27.43 | 5.76 | 261,266.70 | 2.00 | 1.17 | 2.74 | 1.63 | 26.70 | 26.33 | 4.93 | 3.03 | 1.57 | 2.42 | 0.4522 | -- | 8.03 | 9.14 | 78.21 | -- | 17.41 | -- |
| Evolent Health Inc | 1.96bn | -142.26m | 3.48bn | 4.70k | -- | 3.21 | -- | 1.77 | -1.28 | -1.28 | 17.65 | 10.94 | 0.8733 | -- | 5.60 | 417,850.20 | -5.03 | -9.60 | -6.67 | -12.59 | 23.45 | 24.50 | -5.76 | -13.66 | -- | 0.2685 | 0.3239 | -- | 45.26 | 25.65 | -660.71 | -- | -6.18 | -- |
| Radnet Inc | 1.62bn | 3.04m | 3.57bn | 7.87k | 54,255.55 | 5.26 | 22.52 | 2.21 | 0.0009 | 0.0009 | 25.32 | 9.28 | 0.631 | -- | 8.64 | 205,364.60 | 1.18 | 1.24 | 1.56 | 1.66 | 21.67 | 21.56 | 1.88 | 1.86 | -- | 1.47 | 0.5051 | 0.00 | 13.05 | 10.64 | -71.42 | -37.63 | 19.60 | -- |
| Select Medical Holdings Corp | 6.66bn | 234.72m | 3.62bn | 38.40k | 14.92 | 2.81 | 7.11 | 0.5426 | 1.89 | 1.89 | 53.76 | 10.04 | 0.868 | -- | 7.08 | 173,543.20 | 3.90 | 4.19 | 4.84 | 5.46 | 13.99 | 13.98 | 4.50 | 5.11 | -- | 3.52 | 0.7009 | 15.30 | 5.22 | 5.57 | 53.03 | 11.98 | 6.50 | -- |
| Irhythm Technologies Inc | 492.68m | -123.41m | 3.62bn | 2.00k | -- | 17.14 | -- | 7.35 | -4.04 | -4.04 | 16.14 | 6.79 | 1.12 | 11.05 | 8.85 | 246,340.50 | -28.00 | -21.92 | -36.04 | -26.77 | 67.35 | 69.39 | -25.05 | -25.75 | 2.02 | -26.91 | 0.1426 | -- | 19.90 | 27.32 | -6.24 | -- | 50.82 | -- |
| PACS Group Inc | -100.00bn | -100.00bn | 3.66bn | 32.43k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 28.47 | -- | -25.00 | -- | -- | -- |
Data as of Apr 24 2024. Currency figures normalised to QuidelOrtho Corp's reporting currency: US Dollar USD
43.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 8.70m | 13.01% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 4.77m | 7.13% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 4.34m | 6.49% |
| Senvest Management LLCas of 31 Dec 2023 | 3.00m | 4.49% |
| ArrowMark Colorado Holdings LLCas of 31 Dec 2023 | 2.66m | 3.98% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.53m | 2.29% |
| JPMorgan Investment Management, Inc.as of 31 Dec 2023 | 1.20m | 1.80% |
| Burgundy Asset Management Ltd.as of 31 Dec 2023 | 1.16m | 1.74% |
| Rubric Capital Management LPas of 31 Dec 2023 | 980.06k | 1.47% |
| LGT Capital Partners AG (Investment Management)as of 31 Dec 2023 | 954.47k | 1.43% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
